Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Additionally we are shipping Tyrosyl-tRNA Synthetase Proteins (12) and many more products for this protein.
Showing 10 out of 67 products:
Human Polyclonal Yars Primary Antibody for EIA, IHC (p) - ABIN359750
Yang, Kapoor, Otero, Slike, Tsuruta, Frausto, Bates, Ewalt, Cheresh, Schimmel: Gain-of-function mutational activation of human tRNA synthetase procytokine. in Chemistry & biology 2007
Show all 3 references for 359750
Human Polyclonal Yars Primary Antibody for EIA, WB - ABIN359749
Jordanova, Irobi, Thomas, Van Dijck, Meerschaert, Dewil, Dierick, Jacobs, De Vriendt, Guergueltcheva, Rao, Tournev, Gondim, DHooghe, Van Gerwen, Callaerts, Van Den Bosch, Timmermans, Robberecht et al.: Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. ... in Nature genetics 2006
Show all 3 references for 359749
Human Monoclonal Yars Primary Antibody for ELISA, WB - ABIN522023
Storkebaum, Leitão-Gonçalves, Godenschwege, Nangle, Mejia, Bosmans, Ooms, Jacobs, Van Dijck, Yang, Schimmel, Norga, Timmerman, Callaerts, Jordanova: Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot-Marie-Tooth neuropathy. in Proceedings of the National Academy of Sciences of the United States of America 2009
This study showed that show that apoptotic loser cells secrete Tyrosyl-tRNA synthetase, which is best known as a core component of the translational machinery.
Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot-Marie-Tooth neuropathy.
Studied the structural effect of three Charcot-Marie-Tooth disease-causing mutations in tyrosyl-tRNA synthetase. The mutations do not induce changes in protein secondary structures, or shared effects on oligomerization state and stability. However, all mutations provide access to a surface masked in the wild-type enzyme, and that access correlates with protein misinteraction.
Data show that the internal deletion of tyrosyl-tRNA synthetase TyrRSDeltaE2-4 splice variants (SVs (show FGFR2 Antibodies)) gave an alternative, neomorphic dimer interface 'orthogonal' to that of native TyrRS.
Expression of CMT-mutant tyrosyl-tRNA synthetase in Drosophila impairs protein translation.
Computational modeling of molecular dynamics of G41R mutant form of human tyrosyl-tRNA synthetase, assosiated with Charcot-Marie-Tooth neuropathy has been presented.
the association of rare YARS variant with late-onset autosomal dominant Charcot-Marie-Tooth neuropathy
nuclear-localized TyrRS activates transcription factor E2F1 (show E2F1 Antibodies) to upregulate the expression of DNA damage repair genes such as BRCA1 and RAD51 (show RAD51 Antibodies).
A major difference between the first- and second-generation tRNA synthetases (RSs (show GRB10 Antibodies)) is that the second-generation RSs (show GRB10 Antibodies) have an active site more compatible with tyrosine binding.
The full length tyrosyl-tRNA synthetase lacks its cytokine activity because of the interactions between N-terminal and the C-terminal modules, which protect the ELR cytokine motif.
Naturally occurring fragments of the two proteins involved in translation, TyrRS and TrpRS (show WARS Antibodies), have opposing activities on angiogenesis.
Nuclear import of TyrRS is regulated by tRNA(Tyr (show TYR Antibodies)).
Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Tyrosyl-tRNA synthetase belongs to the class I tRNA synthetase family. Cytokine activities have also been observed for the human tyrosyl-tRNA synthetase, after it is split into two parts, an N-terminal fragment that harbors the catalytic site and a C-terminal fragment found only in the mammalian enzyme. The N-terminal fragment is an interleukin-8-like cytokine, whereas the released C-terminal fragment is an EMAP II-like cytokine.
tyrosine--tRNA ligase, cytoplasmic
, tyrosyl--tRNA ligase
, tyrosyl-tRNA synthetase, cytoplasmic
, tyrosyl-tRNA synthetase
, Tyrosyl-tRNA synthetase, cytoplasmic
, tyrosine tRNA ligase 1, cytoplasmic